MARATTO

article · Future Medicinal Chemistry

Harnessing molecular hybridization approach to discover novel quinoline EGFR-TK inhibitors for cancer treatment

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

Accordingly, the afforded quinoline derivatives can be used as promising lead anticancer candidates for future optimization.

Research topics

  • Lung Cancer Treatments and Mutations
  • Cancer therapeutics and mechanisms
  • HER2/EGFR in Cancer Research

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1080/17568919.2024.2342201

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.